0001213900-23-007992.txt : 20230203 0001213900-23-007992.hdr.sgml : 20230203 20230203161355 ACCESSION NUMBER: 0001213900-23-007992 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230202 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTELL RON CENTRAL INDEX KEY: 0001177079 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39138 FILM NUMBER: 23585922 MAIL ADDRESS: STREET 1: PONIARD PHARMACEUTICALS, INC. STREET 2: 750 BATTERY STREET, SUITE 330 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jasper Therapeutics, Inc. CENTRAL INDEX KEY: 0001788028 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842984849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 6505491400 MAIL ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp DATE OF NAME CHANGE: 20190912 4 1 ownership.xml X0306 4 2023-02-02 0 0001788028 Jasper Therapeutics, Inc. JSPR 0001177079 MARTELL RON C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE 102 REDWOOD CITY CA 94065 1 1 0 0 President, CEO & Director Stock Option (right to buy) 1.78 2023-02-02 4 A 0 1093831 0.00 A 2033-02-02 Voting Common Stock 1093831 1093831 D 1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. /s/ Ronald A. Martell 2023-02-03